Cell and gene therapy manufacturing platform
| Date | Round | Amount |
|---|---|---|
| Jan 2022 | Series B Ori Biotech raised over USD100M Series B led by Novalis LifeSciences. | $100M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.